Calciphylaxis Companies

ID: MRFR/Pharma/2425-CR

152 Pages

Kinjoll Dey

August 2017

Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare and serious medical condition characterized by the calcification of small and medium-sized blood vessels, leading to tissue ischemia and necrosis. This condition often occurs in patients with chronic kidney disease, particularly those undergoing dialysis. Companies involved in the field of calciphylaxis may be focused on research, development, and commercialization of diagnostic tools, therapeutic interventions, and supportive care for individuals affected by this condition.

Calciphylaxis Market Research Report - Forecast till 2032 Infographic

Summary Table of Contents Segmentation Infographic

Top Industry Leaders in the Calciphylaxis Market

Calciphylaxis Key Companies

Latest Calciphylaxis Companies Update

Calciphylaxis Diagnostic Markers Several companies are investigating novel biomarkers for early detection and diagnosis of calciphylaxis. For example, RenalytixAI is conducting a study exploring the potential of its AI-powered urine diagnostic platform for this purpose.

Novel Treatment Approaches Clinical trials are evaluating potential new therapies for calciphylaxis, including sodium thiosulfate (STS) in different formulations and combinations with other medications.

List of Calciphylaxis Key Companies in the Market

LaboratorisSanifit S.L.

Medtronic Plc.

ConvaTec Inc.

BSN Medical

Amgen Inc.

Smith & Nephew Plc.

3M Company